MDX LIFESCIENCES is a clinical stage biotechnology company developing autologous transplantation for tissue and organ regeneration. Its development programs are focused on myocardial ischemia, reperfusion injury as well as on neurodegenerative and neuromuscular diseases. The company provides MDXViewer, a monitoring system that analyzes the physiological activities at the tissue level integrated with systemic vital signs.